Still, Pfizer has decided to discontinue danuglipron after a review of the totality of information, including all clinical data generated to date and recent input from regulators. With the discontinuation of danuglipron, Pfizer is now down to one clinical-stage obesity asset: the oral GIP analog PF-07976016, which is currently in Phase II development
Were seeing great results from this combo at our centers, with promising outcomes, especially in patients over 40
This suggests that for many people, 10 mg represents the point of diminishing returns, where side effects increase more than benefits
It works on a cellular level by activating an enzyme called AMPK, which helps regulate metabolism
body composition also plays a role
This rural track expansion will ultimately grow to a complement of four OB/GYN residents training on-site at Colquitt Regional at one time